{
  "id": "michigan_picc_risk",
  "title": "Michigan Risk Score for PICC-Related Thrombosis",
  "description": "Predicts risk of deep vein thrombosis (DVT) in patients with peripherally inserted central catheter (PICC)",
  "category": "hematology",
  "version": "2017",
  "parameters": [
    {
      "name": "another_cvc_present",
      "type": "string",
      "required": true,
      "description": "Is another central venous catheter (CVC) present when PICC is placed?",
      "options": ["no", "yes"],
      "validation": {
        "enum": ["no", "yes"]
      }
    },
    {
      "name": "wbc_over_12",
      "type": "string",
      "required": true,
      "description": "Is white blood cell count > 12.0 × 10⁹/µL?",
      "options": ["no", "yes"],
      "validation": {
        "enum": ["no", "yes"]
      }
    },
    {
      "name": "picc_lumens",
      "type": "string",
      "required": true,
      "description": "Number of PICC lumens",
      "options": ["1", "2", "3_or_4"],
      "validation": {
        "enum": ["1", "2", "3_or_4"]
      }
    },
    {
      "name": "history_of_vte",
      "type": "string",
      "required": true,
      "description": "History of venous thromboembolism (VTE)?",
      "options": ["never", "yes_over_30_days", "yes_within_30_days"],
      "validation": {
        "enum": ["never", "yes_over_30_days", "yes_within_30_days"]
      }
    },
    {
      "name": "active_cancer",
      "type": "string",
      "required": true,
      "description": "Active cancer (on chemotherapy or cancer-related admission)?",
      "options": ["no", "yes"],
      "validation": {
        "enum": ["no", "yes"]
      }
    }
  ],
  "result": {
    "name": "michigan_picc_risk_score",
    "type": "integer",
    "unit": "points",
    "description": "Risk score for PICC-related thrombosis"
  },
  "interpretation": {
    "ranges": [
      {
        "min": 0,
        "max": 0,
        "stage": "Class I",
        "description": "0.9% VTE probability",
        "interpretation": "Low risk of PICC-related thrombosis. Standard monitoring and VTE prophylaxis as per institutional protocol."
      },
      {
        "min": 1,
        "max": 2,
        "stage": "Class II",
        "description": "1.6% VTE probability",
        "interpretation": "Low-moderate risk of PICC-related thrombosis. Consider enhanced monitoring for VTE symptoms."
      },
      {
        "min": 3,
        "max": 4,
        "stage": "Class III",
        "description": "2.7% VTE probability",
        "interpretation": "Moderate-high risk of PICC-related thrombosis. Consider alternative vascular access if feasible, or implement enhanced VTE prophylaxis and monitoring."
      },
      {
        "min": 5,
        "max": 10,
        "stage": "Class IV",
        "description": "4.7% VTE probability",
        "interpretation": "High risk of PICC-related thrombosis. Strongly consider alternative vascular access options. If PICC necessary, implement aggressive VTE prophylaxis and frequent monitoring."
      }
    ]
  },
  "references": [
    "Chopra V, Kaatz S, Conlon A, Paje D, Grant PJ, Rogers MAM, et al. The Michigan Risk Score to predict peripherally inserted central catheter-associated thrombosis. J Thromb Haemost. 2017 Oct;15(10):1951-1962. doi: 10.1111/jth.13794.",
    "Chopra V, Anand S, Hickner A, Buist M, Rogers MA, Saint S, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet. 2013 Jul 27;382(9889):311-25. doi: 10.1016/S0140-6736(13)60592-9.",
    "Evans RS, Sharp JH, Linford LH, Lloyd JF, Tripp JS, Jones JP, et al. Risk of symptomatic DVT associated with peripherally inserted central catheters. Chest. 2010 Oct;138(4):803-10. doi: 10.1378/chest.10-0154."
  ],
  "formula": "Sum of points: Another CVC (+1), WBC >12 (+1), 2 lumens (+1), 3-4 lumens (+2), VTE >30 days prior (+2), VTE within 30 days (+3), Active cancer (+3)",
  "notes": [
    "Developed from Michigan Hospital Medicine Safety Consortium data",
    "Validated in medical patients ≥18 years old",
    "Not validated for surgical patients, pediatric patients, or pregnant patients",
    "2.1% overall PICC-DVT rate in development cohort of 23,010 patients",
    "Risk increases 5.2-fold from Class I to Class IV",
    "Consider alternative vascular access for high-risk patients",
    "Some validation studies have shown mixed results regarding accuracy"
  ]
}